Haihong jin
Seminars
Thursday 3rd December 2026
Advancing PSMA Radiopharmaceuticals into the Clinic: Lessons Learned from Navigating the CDE Approval Pathway
11:00 am
- Sharing the development journey of a PSMA-targeted radiopharmaceutical from preclinical development through to Phase I clinical evaluation
- Exploring key considerations when preparing regulatory submissions to the Chinese CDE and identifying opportunities to accelerate clinical entry
- Understanding the similarities and differences between CDE and FDA expectations for radiopharmaceutical development
- Highlighting practical lessons learned from generating the data package required to support successful first-in-human studies and future global development
